Eagle Pharmaceuticals shares owned by Capital Impact Advisors
Quarter-by-quarter ownership of Eagle Pharmaceuticals (EGRX) shares owned by Capital Impact Advisors
from 13F filings
Historical chart of Capital Impact Advisors investment in Eagle Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Eagle Pharmaceuticals held by Capital Impact Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Eagle Pharmaceuticals by Capital Impact Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-06-30 | $489k | 25k | 19.44 |
| 2023-03-31 | $386k | 14k | 28.37 |
| 2022-12-31 | $371k | 13k | 29.23 |
| 2022-09-30 | $465k | 13k | 36.60 |
| 2022-06-30 | $521k | 12k | 44.42 |
| 2022-03-31 | $788k | 16k | 49.50 |
| 2021-12-31 | $982k | 19k | 50.94 |
| 2021-09-30 | $1.1M | 19k | 55.77 |
| 2021-06-30 | $825k | 19k | 42.80 |
| 2021-03-31 | $1.5M | 36k | 41.74 |
| 2020-12-31 | $1.7M | 36k | 46.57 |
| 2020-09-30 | $1.5M | 36k | 42.47 |
| 2020-06-30 | $1.7M | 36k | 47.97 |
| 2020-03-31 | $1.6M | 36k | 45.99 |
| 2019-12-31 | $2.0M | 34k | 60.07 |
| 2019-09-30 | $1.9M | 34k | 56.43 |
| 2019-06-30 | $1.9M | 35k | 54.99 |
| 2019-03-31 | $1.3M | 34k | 39.22 |
| 2018-12-31 | $1.3M | 34k | 39.22 |
| 2018-09-30 | $1.7M | 24k | 68.93 |
| 2018-06-30 | $1.8M | 24k | 75.94 |
| 2018-03-31 | $1.4M | 26k | 52.70 |
Top funds holding Eagle Pharmaceuticals
View all funds holding Eagle Pharmaceuticals